263 Followers on Owler

BTG International

Read more
Dame Louise Makin's photo - CEO of BTG International

CEO

Dame Louise Makin

CEO Approval Rating

90/100

Founded:

1948

Est. Annual Revenue
Est. Employees

BTG INTERNATIONAL TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Novartis is seen as one of BTG International's top competitors. Novartis was founded in Basel, Basel-City} in 1996. Novartis is in the Pharmaceuticals industry. Compared to BTG International, Novartis generates $49.5B more revenue.

Pfizer is BTG International's #2 competitor. Pfizer was founded in 1849, and its headquarters is in New York, New York. Pfizer competes in the Pharmaceuticals industry. Pfizer has 76,990 more employees than BTG International.

Merck is BTG International's #3 rival. Merck is headquartered in Kenilworth, New Jersey, and was founded in 1891. Like BTG International, Merck also competes in the Pharmaceuticals industry. Merck generates 5,516% the revenue of BTG International.

BTG International Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Novate Pi042 Issue

Sep 2018

Source »
$20M
Novate develops and commercializes novel bio-convertible IVC filtration devices for the protection against pulmonary embolism conditions.
Roxwood Medical, Inc.

Oct 2017

Source »
$65M
Roxwood Medical is a provider of cardiovascular specialty catheters for the treatment of coronary and peripheral artery diseases.
Galil Medical, Inc.

May 2016

Source »
$84.5M
Galil Medical designs and develops novel minimally-invasive cryotherapy solutions for the cryosurgical ablation of benign tissue and cancerous tumors.
PneumRx, Inc.

Dec 2014

Source »
$230M
PneumRx develops minimally invasive treatments for emphysema.
EKOS Corporation

May 2013

Source »
$181.3M
EKOS is a developer of medical devices and thrombolytic drugs for the treatment of vascular thrombosis.

These are all the companies that BTG International has acquired. BTG International has acquired 6 companies and its latest acquisition was Novate Pi042 Issue in Sep 2018. Novate develops and commercializes novel bio-convertible IVC filtration devices for the protection against pulmonary embolism conditions.

BTG International Funding History

Since BTG International was founded in 1948, it has participated in 2 rounds of funding. In total BTG International has raised $7.9M. BTG International's last funding round was on Jun 2015 for a total of $3.9M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Unattributed
Jun 2015
$3.9M
-
Unattributed
Jan 2015
$4.1M
-

Since BTG International was founded in 1948, it has participated in 2 rounds of funding. In total BTG International has raised $7.9M. BTG International's last funding round was on Jun 2015 for a total of $3.9M

BTG International Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Veran is a medical device company that manufactures and distributes lung cancer diagnosing equipment for the healthcare industry.
$20M
Nov 13, 2018
Equity
-

These are all the companies that BTG International has invested in. BTG International's latest investment was Veran in Nov 13,. Veran is a medical device company that manufactures and distributes lung cancer diagnosing equipment for the healthcare industry.

BTG International News

BTG International Press Releases

BTG International Videos

Social Media

BTG International Headquarters

5 Fleet Place

London, EnglandEC4M 7RD

1-844-293-0007

Driving Directions »

Trending Companies

BTG International Summary

ABOUT

Overview

BTG focuses on developing and commercializing of pharma products for cancer, vascular and emphysema diseases. BTG International was founded in 1948. BTG International's headquarters is located in London, England, GB EC4M 7RD. It has raised 7.9M in 2 r...

CEO

BTG International's CEO, Dame Louise Makin, currently has an approval rating of 90%. BTG International's primary competitors are Novartis, Pfizer & Merck.

Website

btgplc.com

Frequently Asked Questions about BTG International

  1. When was BTG International founded?

    BTG International was founded in 1948
  2. Who is BTG International's CEO?

    BTG International's CEO is Dame Louise Makin
  3. How much revenue does BTG International generate?

    BTG International generates $870.5M in revenue
  4. How much funding does BTG International have?

    BTG International has historically raised $7.9M in funding
  5. Where is BTG International's headquarters?

    BTG International's headquarters is in London England, GB
  1. How many employees does BTG International have?

    BTG International has 1,510 employees
  2. What sector does BTG International operate in?

    BTG International is in Pharmaceuticals
  3. Who are BTG International's competitors?

    BTG International's top competitors are Novartis, Pfizer, Merck
  4. Who has BTG International invested in?

    BTG International's has invested in companies such as Veran